Cancer Drug Doxil Receives U.S FDA Approval

by Savitha C Muppala on  February 10, 2013 at 12:14 AM Drug News
RSS Email Print This Page Comment
Sun Pharmaceutical Industries Ltd. (SUNP), has received the approval by the U.S FDA for the company's generic version of Johnson & Johnson (JNJ)'s cancer drug Doxil.
Cancer Drug Doxil Receives U.S FDA Approval
Cancer Drug Doxil Receives U.S FDA Approval
Advertisement

The U.S. Food & Drug Administration has permitted the sales of Sun Pharma's version of the drug to help with the treatment of patients with ovarian cancer that has progressed or recurred.

Advertisement
According to statistics, a revenue of nearly $402 million has already been generated for J&J in 2011 .

Market analysts have said that this is a very important approval for Sun Pharma. Indeed, it is the first generic player to get an approval for this drug. It is also expected to enjoy exclusivity for the ensuing months.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Drug Toxicity Cancer and Homeopathy Signature Drug Toxicity Cancer Facts Cancer Tattoos A Body Art Oncology Drug Delivery Systems Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant 
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive